Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.
Mirvie has raised $23.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2025.
Mirvie's investors include General Catalyst, BlackRock, Khosla Ventures, Mayfield Fund, Foresite Capital.
Mirvie is headquartered in South San Francisco, United States.
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.
Mirvie is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mirvie — Funding & Investors." VCBacked, August 1, 2025, https://www.vcbacked.co/company/mirvie. Accessed September 1, 2026.
VCBacked. (2025). Mirvie — Funding & Investors. Retrieved September 1, 2026, from https://www.vcbacked.co/company/mirvie
{{cite web |title=Mirvie — Funding & Investors |url=https://www.vcbacked.co/company/mirvie |website=VCBacked |access-date=September 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated